Jump to the top of the page

William Blair Thinking

  • Opportunistic Activity Defies Gravity

    Opportunistic activity soared in the fourth quarter as borrowers capitalized on tightening spreads, closing out a record-setting year driven by the combination of rate cuts, a more stabilized economic outlook, and robust investor demand.

    Read more
  • We’re on IT: Navigating 2025’s Dynamic IT Services Landscape

    In this episode of William Blair Thinking Presents, technology analyst Maggie Nolan, partner, CPA, dives into the latest trends in IT services, exploring the impact of generative AI, data infrastructure, and political influences on the industry.

    Listen to the podcast
  • The 2025 Tax Reference Guide

    William Blair's tax reference guide for income earned in 2025 and tax returns filed in 2026 is now available.

    Read more

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • William Blair Names John Ivey, B.T. Remmert Co-Heads of Technology Investment Banking

    William Blair has named managing directors John Ivey and B.T. Remmert as the firm’s co-heads of Technology investment banking.

    Read more
  • Rubrik, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Rubrik, Inc. (RBRK $75.59), a leading vendor in the fast-evolving data protection (DP) industry, pioneering a next-generation approach to data backup and transforming perceptions of DP technology from “boring old backup” to a must-have cyber resilience platform.

    Read more
  • Mersana Therapeutics, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Mersana Therapeutics, Inc. (MRSN $0.57), whose lead program emiltatug ledadotin is an ADC that targets B7-H4; it is in Phase I development for TNBC. The company is also developing a HER2-targeted immune-stimulating ADC, XMT-2056, in a Phase I solid tumor study.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures